Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

Detailed price information for Bioaffinity Technologies WT (BIAFW-Q) from The Globe and Mail including charting and trades.

Researchers have developed a way to predict how lung cancer cells will respond to different therapies, allowing people with ...

Affinity Technologies' stock surged after a patent notice and Nasdaq compliance update but slipped in after-hours trading.

Imagine being armed with precautionary measures to fight a disease – like being vaccinated before the flu season arrives. What if we could have a similar kind of preparedness for a dangerous disease ...

DeepSeek, a blood test that can detect HPV-linked head and neck cancers nearly a decade before diagnosis. By finding viral DNA in the bloodstream, the test achieved 99% sensitivity and specificity.

More Than Half of Cancers Detected by Galleri Were Early Stage Approximately Three-Quarters of Galleri-Detected Cancers Do Not Have Recommended Screenings ...

THE march of AI now seems unstoppable in every part of our lives, from choosing the TV we watch to making our trains run on ...

Investing.com -- bioAffinity Technologies Inc (NASDAQ:BIAF) stock surged 14% on Thursday after the biotechnology company announced it received a notification of allowance from the United States Patent ...